|
|
|
|
|
|
|
|
|
|
open access
Combination of Bevacizumab and Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: Some Observations About the AURELIA Trial
Tuesday, November 11, 2014
Correspondence: Combination of Bevacizumab and Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer:(AURELIA Trial)
open access
Combination of Bevacizumab and Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: Some Observations About the AURELIA Trial
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.